Tuberculosis (TB) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Tuberculosis (TB) Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Tuberculosis (TB) Treatment are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Tuberculosis (TB) Treatment market segmented into
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Based on the end-use, the global Tuberculosis (TB) Treatment market classified into
Active TB
Latent TB

Based on geography, the global Tuberculosis (TB) Treatment market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TUBERCULOSIS (TB) TREATMENT INDUSTRY
2.1 Summary about Tuberculosis (TB) Treatment Industry
2.2 Tuberculosis (TB) Treatment Market Trends
2.2.1 Tuberculosis (TB) Treatment Production & Consumption Trends
2.2.2 Tuberculosis (TB) Treatment Demand Structure Trends
2.3 Tuberculosis (TB) Treatment Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Isoniazid
4.2.2 Rifampin (Rifadin, Rimactane)
4.2.3 Ethambutol (Myambutol)
4.2.4 Pyrazinamide
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Active TB
4.3.2 Latent TB
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Isoniazid
5.2.2 Rifampin (Rifadin, Rimactane)
5.2.3 Ethambutol (Myambutol)
5.2.4 Pyrazinamide
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Active TB
5.3.2 Latent TB
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Isoniazid
6.2.2 Rifampin (Rifadin, Rimactane)
6.2.3 Ethambutol (Myambutol)
6.2.4 Pyrazinamide
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Active TB
6.3.2 Latent TB
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Isoniazid
7.2.2 Rifampin (Rifadin, Rimactane)
7.2.3 Ethambutol (Myambutol)
7.2.4 Pyrazinamide
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Active TB
7.3.2 Latent TB
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Isoniazid
8.2.2 Rifampin (Rifadin, Rimactane)
8.2.3 Ethambutol (Myambutol)
8.2.4 Pyrazinamide
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Active TB
8.3.2 Latent TB
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Isoniazid
9.2.2 Rifampin (Rifadin, Rimactane)
9.2.3 Ethambutol (Myambutol)
9.2.4 Pyrazinamide
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Active TB
9.3.2 Latent TB
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Johnson & Johnson
10.1.2 Otsuka Pharmaceutical Co., Ltd
10.1.3 Macleods Pharmaceutical Ltd
10.1.4 Dong-A ST Co., Ltd
10.1.5 Lupin Ltd
10.1.6 Janssen Products, LP
10.1.7 Mylan
10.1.8 Sanofi
10.2 Tuberculosis (TB) Treatment Sales Date of Major Players (2017-2020e)
10.2.1 Johnson & Johnson
10.2.2 Otsuka Pharmaceutical Co., Ltd
10.2.3 Macleods Pharmaceutical Ltd
10.2.4 Dong-A ST Co., Ltd
10.2.5 Lupin Ltd
10.2.6 Janssen Products, LP
10.2.7 Mylan
10.2.8 Sanofi
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Tuberculosis (TB) Treatment Product Type Overview
2.Table Tuberculosis (TB) Treatment Product Type Market Share List
3.Table Tuberculosis (TB) Treatment Product Type of Major Players
4.Table Brief Introduction of Johnson & Johnson
5.Table Brief Introduction of Otsuka Pharmaceutical Co., Ltd
6.Table Brief Introduction of Macleods Pharmaceutical Ltd
7.Table Brief Introduction of Dong-A ST Co., Ltd
8.Table Brief Introduction of Lupin Ltd
9.Table Brief Introduction of Janssen Products, LP
10.Table Brief Introduction of Mylan
11.Table Brief Introduction of Sanofi
12.Table Products & Services of Johnson & Johnson
13.Table Products & Services of Otsuka Pharmaceutical Co., Ltd
14.Table Products & Services of Macleods Pharmaceutical Ltd
15.Table Products & Services of Dong-A ST Co., Ltd
16.Table Products & Services of Lupin Ltd
17.Table Products & Services of Janssen Products, LP
18.Table Products & Services of Mylan
19.Table Products & Services of Sanofi
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Tuberculosis (TB) Treatment Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Tuberculosis (TB) Treatment Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Tuberculosis (TB) Treatment Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Tuberculosis (TB) Treatment Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Tuberculosis (TB) Treatment Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Tuberculosis (TB) Treatment Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Tuberculosis (TB) Treatment Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Isoniazid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Rifampin (Rifadin, Rimactane) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Ethambutol (Myambutol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Pyrazinamide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Active TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Latent TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Isoniazid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Rifampin (Rifadin, Rimactane) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Ethambutol (Myambutol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Pyrazinamide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Active TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Latent TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Isoniazid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rifampin (Rifadin, Rimactane) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Ethambutol (Myambutol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Pyrazinamide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Active TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Latent TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Isoniazid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Rifampin (Rifadin, Rimactane) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Ethambutol (Myambutol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Pyrazinamide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Active TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Latent TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Isoniazid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Rifampin (Rifadin, Rimactane) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Ethambutol (Myambutol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Pyrazinamide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Active TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Latent TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Isoniazid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rifampin (Rifadin, Rimactane) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Ethambutol (Myambutol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Pyrazinamide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Active TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Latent TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Tuberculosis (TB) Treatment Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
72.Figure Tuberculosis (TB) Treatment Sales Revenue (Million USD) of Otsuka Pharmaceutical Co., Ltd 2017-2020e
73.Figure Tuberculosis (TB) Treatment Sales Revenue (Million USD) of Macleods Pharmaceutical Ltd 2017-2020e
74.Figure Tuberculosis (TB

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2021 Worldwide Market Reports. All rights reserved